Inventor
Lihui QIAN
Inventor
CN
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes23%
C07BGeneral methods of organic chemistry8%
Y02PClimate change mitigation technologies in the production or processing of goods8%
PatentTitleYear
12,577,2501,2,4-triazolone derivative as DHODH inhibitor, and preparation method therefor and use thereof202612,559,505IDH mutant inhibitor and use thereof202612,522,607Substituted pyrazolo[3,4-d]pyrimidines as wee-1 inhibitors202612,497,397Pyrrole compounds useful as antifungals202512,479,843Spiro ring-containing quinazoline compounds202512,391,692Spiro ring-containing quinazoline compound202512,275,726Aurora kinase inhibitors and use thereof202512,122,774Compounds as MYT1 inhibitors2024Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2024–2026Patents assigned to WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (8)· patent assignee history
2024–2026Based in CN· patent location history
2025Patents assigned to UNIV SOOCHOW (1)· patent assignee history
2025Patents assigned to WIGEN BOIMEDICINE TECH SHANGHAI CO LTD (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| WIGEN BIOMEDICINE TECH SHANGHAI CO LTD | 8 | 2024–2026 |
| UNIV SOOCHOW | 1 | 2025 |
| WIGEN BOIMEDICINE TECH SHANGHAI CO LTD | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| CN | 8 | 2024–2026 |